Global Ipilimumab Market Growth 2020-2025
According to this study, over the next five years the Ipilimumab market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ipilimumab business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Ipilimumab market by type, application, key manufacturers and key regions and countries.
This study considers the Ipilimumab value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
PD - L1 Antagonists
CTLA4 Antagonists
Immunocheckpoint Inhibitors
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer
Melanoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Gilead
BMS
Roche
Prestige BioPharma
Ono
Shenyang Sansheng Pharmaceutical
Avacta
Baxter
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Ipilimumab consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Ipilimumab market by identifying its various subsegments.
Focuses on the key global Ipilimumab manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ipilimumab with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Ipilimumab submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ipilimumab Consumption 2015-2025
2.1.2 Ipilimumab Consumption CAGR by Region
2.2 Ipilimumab Segment by Type
2.2.1 PD - L1 Antagonists
2.2.2 CTLA4 Antagonists
2.2.3 Immunocheckpoint Inhibitors
2.2.4 Other
2.3 Ipilimumab Consumption by Type
2.3.1 Global Ipilimumab Consumption Market Share by Type (2015-2020)
2.3.2 Global Ipilimumab Revenue and Market Share by Type (2015-2020)
2.3.3 Global Ipilimumab Sale Price by Type (2015-2020)
2.4 Ipilimumab Segment by Application
2.4.1 Cancer
2.4.2 Melanoma
2.5 Ipilimumab Consumption by Application
2.5.1 Global Ipilimumab Consumption Market Share by Type (2015-2020)
2.5.2 Global Ipilimumab Value and Market Share by Type (2015-2020)
2.5.3 Global Ipilimumab Sale Price by Type (2015-2020)
3 Global Ipilimumab by Company
3.1 Global Ipilimumab Sales Market Share by Company
3.1.1 Global Ipilimumab Sales by Company (2018-2020)
3.1.2 Global Ipilimumab Sales Market Share by Company (2018-2020)
3.2 Global Ipilimumab Revenue Market Share by Company
3.2.1 Global Ipilimumab Revenue by Company (2018-2020)
3.2.2 Global Ipilimumab Revenue Market Share by Company (2018-2020)
3.3 Global Ipilimumab Sale Price by Company
3.4 Global Ipilimumab Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Ipilimumab Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Ipilimumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Ipilimumab by Regions
4.1 Ipilimumab by Regions
4.2 Americas Ipilimumab Consumption Growth
4.3 APAC Ipilimumab Consumption Growth
4.4 Europe Ipilimumab Consumption Growth
4.5 Middle East & Africa Ipilimumab Consumption Growth
5 Americas
5.1 Americas Ipilimumab Consumption by Countries
5.1.1 Americas Ipilimumab Consumption by Countries (2015-2020)
5.1.2 Americas Ipilimumab Value by Countries (2015-2020)
5.2 Americas Ipilimumab Consumption by Type
5.3 Americas Ipilimumab Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Ipilimumab Consumption by Regions
6.1.1 APAC Ipilimumab Consumption by Regions (2015-2020)
6.1.2 APAC Ipilimumab Value by Regions (2015-2020)
6.2 APAC Ipilimumab Consumption by Type
6.3 APAC Ipilimumab Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Ipilimumab by Countries
7.1.1 Europe Ipilimumab Consumption by Countries (2015-2020)
7.1.2 Europe Ipilimumab Value by Countries (2015-2020)
7.2 Europe Ipilimumab Consumption by Type
7.3 Europe Ipilimumab Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Ipilimumab by Countries
8.1.1 Middle East & Africa Ipilimumab Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Ipilimumab Value by Countries (2015-2020)
8.2 Middle East & Africa Ipilimumab Consumption by Type
8.3 Middle East & Africa Ipilimumab Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Ipilimumab Distributors
10.3 Ipilimumab Customer
11 Global Ipilimumab Market Forecast
11.1 Global Ipilimumab Consumption Forecast (2021-2025)
11.2 Global Ipilimumab Forecast by Regions
11.2.1 Global Ipilimumab Forecast by Regions (2021-2025)
11.2.2 Global Ipilimumab Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Ipilimumab Forecast by Type
11.8 Global Ipilimumab Forecast by Application
12 Key Players Analysis
12.1 Gilead
12.1.1 Company Information
12.1.2 Ipilimumab Product Offered
12.1.3 Gilead Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Gilead Latest Developments
12.2 BMS
12.2.1 Company Information
12.2.2 Ipilimumab Product Offered
12.2.3 BMS Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 BMS Latest Developments
12.3 Roche
12.3.1 Company Information
12.3.2 Ipilimumab Product Offered
12.3.3 Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Roche Latest Developments
12.4 Prestige BioPharma
12.4.1 Company Information
12.4.2 Ipilimumab Product Offered
12.4.3 Prestige BioPharma Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Prestige BioPharma Latest Developments
12.5 Ono
12.5.1 Company Information
12.5.2 Ipilimumab Product Offered
12.5.3 Ono Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Ono Latest Developments
12.6 Shenyang Sansheng Pharmaceutical
12.6.1 Company Information
12.6.2 Ipilimumab Product Offered
12.6.3 Shenyang Sansheng Pharmaceutical Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Shenyang Sansheng Pharmaceutical Latest Developments
12.7 Avacta
12.7.1 Company Information
12.7.2 Ipilimumab Product Offered
12.7.3 Avacta Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Avacta Latest Developments
12.8 Baxter
12.8.1 Company Information
12.8.2 Ipilimumab Product Offered
12.8.3 Baxter Ipilimumab Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Baxter Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Ipilimumab Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of PD - L1 Antagonists
Table 5. Major Players of CTLA4 Antagonists
Table 6. Major Players of Immunocheckpoint Inhibitors
Table 7. Major Players of Other
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Ipilimumab Consumption Market Share by Type (2015-2020)
Table 10. Global Ipilimumab Revenue by Type (2015-2020) ($ million)
Table 11. Global Ipilimumab Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Ipilimumab Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Ipilimumab Consumption Market Share by Application (2015-2020)
Table 15. Global Ipilimumab Value by Application (2015-2020)
Table 16. Global Ipilimumab Value Market Share by Application (2015-2020)
Table 17. Global Ipilimumab Sale Price by Application (2015-2020)
Table 18. Global Ipilimumab Sales by Company (2017-2019) (KG)
Table 19. Global Ipilimumab Sales Market Share by Company (2017-2019)
Table 20. Global Ipilimumab Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Ipilimumab Revenue Market Share by Company (2017-2019)
Table 22. Global Ipilimumab Sale Price by Company (2017-2019)
Table 23. Global Ipilimumab Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Ipilimumab Products Offered
Table 25. Ipilimumab Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Ipilimumab Consumption by Regions 2015-2020 (KG)
Table 27. Global Ipilimumab Consumption Market Share by Regions 2015-2020
Table 28. Global Ipilimumab Value by Regions 2015-2020 ($ Millions)
Table 29. Global Ipilimumab Value Market Share by Regions 2015-2020
Table 30. Americas Ipilimumab Consumption by Countries (2015-2020) (KG)
Table 31. Americas Ipilimumab Consumption Market Share by Countries (2015-2020)
Table 32. Americas Ipilimumab Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Ipilimumab Value Market Share by Countries (2015-2020)
Table 34. Americas Ipilimumab Consumption by Type (2015-2020) (KG)
Table 35. Americas Ipilimumab Consumption Market Share by Type (2015-2020)
Table 36. Americas Ipilimumab Consumption by Application (2015-2020) (KG)
Table 37. Americas Ipilimumab Consumption Market Share by Application (2015-2020)
Table 38. APAC Ipilimumab Consumption by Countries (2015-2020) (KG)
Table 39. APAC Ipilimumab Consumption Market Share by Countries (2015-2020)
Table 40. APAC Ipilimumab Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Ipilimumab Value Market Share by Regions (2015-2020)
Table 42. APAC Ipilimumab Consumption by Type (2015-2020) (KG)
Table 43. APAC Ipilimumab Consumption Market Share by Type (2015-2020)
Table 44. APAC Ipilimumab Consumption by Application (2015-2020) (KG)
Table 45. APAC Ipilimumab Consumption Market Share by Application (2015-2020)
Table 46. Europe Ipilimumab Consumption by Countries (2015-2020) (KG)
Table 47. Europe Ipilimumab Consumption Market Share by Countries (2015-2020)
Table 48. Europe Ipilimumab Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Ipilimumab Value Market Share by Countries (2015-2020)
Table 50. Europe Ipilimumab Consumption by Type (2015-2020) (KG)
Table 51. Europe Ipilimumab Consumption Market Share by Type (2015-2020)
Table 52. Europe Ipilimumab Consumption by Application (2015-2020) (KG)
Table 53. Europe Ipilimumab Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Ipilimumab Consumption by Countries (2015-2020) (KG)
Table 55. Middle East & Africa Ipilimumab Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Ipilimumab Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Ipilimumab Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Ipilimumab Consumption by Type (2015-2020) (KG)
Table 59. Middle East & Africa Ipilimumab Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Ipilimumab Consumption by Application (2015-2020) (KG)
Table 61. Middle East & Africa Ipilimumab Consumption Market Share by Application (2015-2020)
Table 62. Ipilimumab Distributors List
Table 63. Ipilimumab Customer List
Table 64. Global Ipilimumab Consumption Forecast by Countries (2021-2025) (KG)
Table 65. Global Ipilimumab Consumption Market Forecast by Regions
Table 66. Global Ipilimumab Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Ipilimumab Value Market Share Forecast by Regions
Table 68. Global Ipilimumab Consumption Forecast by Type (2021-2025) (KG)
Table 69. Global Ipilimumab Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Ipilimumab Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Ipilimumab Value Market Share Forecast by Type (2021-2025)
Table 72. Global Ipilimumab Consumption Forecast by Application (2021-2025) (KG)
Table 73. Global Ipilimumab Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Ipilimumab Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Ipilimumab Value Market Share Forecast by Application (2021-2025)
Table 76. Gilead Product Offered
Table 77. Gilead Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 78. Gilead Main Business
Table 79. Gilead Latest Developments
Table 80. Gilead Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 81. BMS Product Offered
Table 82. BMS Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 83. BMS Main Business
Table 84. BMS Latest Developments
Table 85. BMS Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche Product Offered
Table 87. Roche Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. Roche Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 91. Prestige BioPharma Product Offered
Table 92. Prestige BioPharma Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 93. Prestige BioPharma Main Business
Table 94. Prestige BioPharma Latest Developments
Table 95. Prestige BioPharma Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 96. Ono Product Offered
Table 97. Ono Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 98. Ono Main Business
Table 99. Ono Latest Developments
Table 100. Ono Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 101. Shenyang Sansheng Pharmaceutical Product Offered
Table 102. Shenyang Sansheng Pharmaceutical Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 103. Shenyang Sansheng Pharmaceutical Main Business
Table 104. Shenyang Sansheng Pharmaceutical Latest Developments
Table 105. Shenyang Sansheng Pharmaceutical Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 106. Avacta Product Offered
Table 107. Avacta Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
Table 108. Avacta Main Business
Table 109. Avacta Latest Developments
Table 110. Avacta Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 111. Baxter Product Offered
Table 112. Baxter Ipilimumab Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 113. Baxter Main Business
Table 114. Baxter Latest Developments
Table 115. Baxter Basic Information, Company Total Revenue (in $ million), Ipilimumab Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Ipilimumab
Figure 2. Ipilimumab Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Ipilimumab Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Ipilimumab Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of PD - L1 Antagonists
Figure 7. Product Picture of CTLA4 Antagonists
Figure 8. Product Picture of Immunocheckpoint Inhibitors
Figure 9. Product Picture of Other
Figure 10. Global Ipilimumab Consumption Market Share by Type (2015-2020)
Figure 11. Global Ipilimumab Value Market Share by Type (2015-2020)
Figure 12. Ipilimumab Consumed in Cancer
Figure 13. Global Ipilimumab Market: Cancer (2015-2020) (KG)
Figure 14. Global Ipilimumab Market: Cancer (2015-2020) ($ Millions)
Figure 15. Ipilimumab Consumed in Melanoma
Figure 16. Global Ipilimumab Market: Melanoma (2015-2020) (KG)
Figure 17. Global Ipilimumab Market: Melanoma (2015-2020) ($ Millions)
Figure 18. Global Ipilimumab Consumption Market Share by Application (2015-2020)
Figure 19. Global Ipilimumab Value Market Share by Application (2015-2020)
Figure 20. Global Ipilimumab Sales Market Share by Company in 2017
Figure 21. Global Ipilimumab Sales Market Share by Company in 2019
Figure 22. Global Ipilimumab Revenue Market Share by Company in 2017
Figure 23. Global Ipilimumab Revenue Market Share by Company in 2019
Figure 24. Global Ipilimumab Sale Price by Company in 2019
Figure 25. Global Ipilimumab Consumption Market Share by Regions 2015-2020
Figure 26. Global Ipilimumab Value Market Share by Regions 2015-2020
Figure 27. Americas Ipilimumab Consumption 2015-2020 (KG)
Figure 28. Americas Ipilimumab Value 2015-2020 ($ Millions)
Figure 29. APAC Ipilimumab Consumption 2015-2020 (KG)
Figure 30. APAC Ipilimumab Value 2015-2020 ($ Millions)
Figure 31. Europe Ipilimumab Consumption 2015-2020 (KG)
Figure 32. Europe Ipilimumab Value 2015-2020 ($ Millions)
Figure 33. Middle East & Africa Ipilimumab Consumption 2015-2020 (KG)
Figure 34. Middle East & Africa Ipilimumab Value 2015-2020 ($ Millions)
Figure 35. Americas Ipilimumab Consumption Market Share by Countries in 2019
Figure 36. Americas Ipilimumab Value Market Share by Countries in 2019
Figure 37. Americas Ipilimumab Consumption Market Share by Type in 2019
Figure 38. Americas Ipilimumab Consumption Market Share by Application in 2019
Figure 39. United States Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 40. United States Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 41. Canada Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 42. Canada Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 43. Mexico Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 44. Mexico Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 45. APAC Ipilimumab Consumption Market Share by Countries in 2019
Figure 46. APAC Ipilimumab Value Market Share by Regions in 2019
Figure 47. APAC Ipilimumab Consumption Market Share by Type in 2019
Figure 48. APAC Ipilimumab Consumption Market Share by Application in 2019
Figure 49. China Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 50. China Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 51. Japan Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 52. Japan Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 53. Korea Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 54. Korea Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 55. Southeast Asia Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 56. Southeast Asia Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 57. India Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 58. India Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 59. Australia Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 60. Australia Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 61. Europe Ipilimumab Consumption Market Share by Countries in 2019
Figure 62. Europe Ipilimumab Value Market Share by Countries in 2019
Figure 63. Europe Ipilimumab Consumption Market Share by Type in 2019
Figure 64. Europe Ipilimumab Consumption Market Share by Application in 2019
Figure 65. Germany Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 66. Germany Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 67. France Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 68. France Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 69. UK Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 70. UK Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 71. Italy Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 72. Italy Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 73. Russia Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 74. Russia Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Ipilimumab Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Ipilimumab Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Ipilimumab Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Ipilimumab Consumption Market Share by Application in 2019
Figure 79. Egypt Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 80. Egypt Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 82. South Africa Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 84. Israel Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 86. Turkey Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Ipilimumab Consumption Growth 2015-2020 (KG)
Figure 88. GCC Countries Ipilimumab Value Growth 2015-2020 ($ Millions)
Figure 89. Global Ipilimumab Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 90. Global Ipilimumab Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Ipilimumab Consumption 2021-2025 (KG)
Figure 92. Americas Ipilimumab Value 2021-2025 ($ Millions)
Figure 93. APAC Ipilimumab Consumption 2021-2025 (KG)
Figure 94. APAC Ipilimumab Value 2021-2025 ($ Millions)
Figure 95. Europe Ipilimumab Consumption 2021-2025 (KG)
Figure 96. Europe Ipilimumab Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Ipilimumab Consumption 2021-2025 (KG)
Figure 98. Middle East & Africa Ipilimumab Value 2021-2025 ($ Millions)
Figure 99. United States Ipilimumab Consumption 2021-2025 (KG)
Figure 100. United States Ipilimumab Value 2021-2025 ($ Millions)
Figure 101. Canada Ipilimumab Consumption 2021-2025 (KG)
Figure 102. Canada Ipilimumab Value 2021-2025 ($ Millions)
Figure 103. Mexico Ipilimumab Consumption 2021-2025 (KG)
Figure 104. Mexico Ipilimumab Value 2021-2025 ($ Millions)
Figure 105. Brazil Ipilimumab Consumption 2021-2025 (KG)
Figure 106. Brazil Ipilimumab Value 2021-2025 ($ Millions)
Figure 107. China Ipilimumab Consumption 2021-2025 (KG)
Figure 108. China Ipilimumab Value 2021-2025 ($ Millions)
Figure 109. Japan Ipilimumab Consumption 2021-2025 (KG)
Figure 110. Japan Ipilimumab Value 2021-2025 ($ Millions)
Figure 111. Korea Ipilimumab Consumption 2021-2025 (KG)
Figure 112. Korea Ipilimumab Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Ipilimumab Consumption 2021-2025 (KG)
Figure 114. Southeast Asia Ipilimumab Value 2021-2025 ($ Millions)
Figure 115. India Ipilimumab Consumption 2021-2025 (KG)
Figure 116. India Ipilimumab Value 2021-2025 ($ Millions)
Figure 117. Australia Ipilimumab Consumption 2021-2025 (KG)
Figure 118. Australia Ipilimumab Value 2021-2025 ($ Millions)
Figure 119. Germany Ipilimumab Consumption 2021-2025 (KG)
Figure 120. Germany Ipilimumab Value 2021-2025 ($ Millions)
Figure 121. France Ipilimumab Consumption 2021-2025 (KG)
Figure 122. France Ipilimumab Value 2021-2025 ($ Millions)
Figure 123. UK Ipilimumab Consumption 2021-2025 (KG)
Figure 124. UK Ipilimumab Value 2021-2025 ($ Millions)
Figure 125. Italy Ipilimumab Consumption 2021-2025 (KG)
Figure 126. Italy Ipilimumab Value 2021-2025 ($ Millions)
Figure 127. Russia Ipilimumab Consumption 2021-2025 (KG)
Figure 128. Russia Ipilimumab Value 2021-2025 ($ Millions)
Figure 129. Spain Ipilimumab Consumption 2021-2025 (KG)
Figure 130. Spain Ipilimumab Value 2021-2025 ($ Millions)
Figure 131. Egypt Ipilimumab Consumption 2021-2025 (KG)
Figure 132. Egypt Ipilimumab Value 2021-2025 ($ Millions)
Figure 133. South Africa Ipilimumab Consumption 2021-2025 (KG)
Figure 134. South Africa Ipilimumab Value 2021-2025 ($ Millions)
Figure 135. Israel Ipilimumab Consumption 2021-2025 (KG)
Figure 136. Israel Ipilimumab Value 2021-2025 ($ Millions)
Figure 137. Turkey Ipilimumab Consumption 2021-2025 (KG)
Figure 138. Turkey Ipilimumab Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Ipilimumab Consumption 2021-2025 (KG)
Figure 140. GCC Countries Ipilimumab Value 2021-2025 ($ Millions)
Figure 141. Gilead Ipilimumab Market Share (2018-2020)
Figure 142. BMS Ipilimumab Market Share (2018-2020)
Figure 143. Roche Ipilimumab Market Share (2018-2020)
Figure 144. Prestige BioPharma Ipilimumab Market Share (2018-2020)
Figure 145. Ono Ipilimumab Market Share (2018-2020)
Figure 146. Shenyang Sansheng Pharmaceutical Ipilimumab Market Share (2018-2020)
Figure 147. Avacta Ipilimumab Market Share (2018-2020)
Figure 148. Baxter Ipilimumab Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets